Clinical trial · Observational
Blinded Resection in Case of the Pancreatic Insulinoma
Blinded Resection Avoided in Case of the Pancreatic Insulinoma
NCT04741152CI-TRIAL-00049888completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The blinded resection avoided in case of pancreatic insulinoma
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Insulinoma; Pancreas | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Pancreatic resection | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Revealed insulinoma
- description
- Cases when the tumor was revealed by the preoperative diagnostics and confirmed after the tumor elimination
- interventionNames
- Procedure: Pancreatic resection
- label
- Hidden Insulioma
- description
- Group when the insulinoma haven't been revealed preoperative and intraoperatively and the blind resection was performed.
- interventionNames
- Procedure: Pancreatic resection
Primary outcomes (1)
- measure
- No hidden insulinomas
- timeFrame
- 2010 June - 2020 June
- description
- To improve the diagnostics of the tumor before and during the surgery. The "hidden" insulinomas haven't been diagnosed. The frozen section have to be routinely performed. The surgery haven't been finished before the morphologic confirmation of the resected lesion.
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: The blinded resection of the insulinoma Exclusion Criteria: Other tumors
References
Publications (0)
Data not yet available
No reference posted for this study.